corporate_fare

Newron Pharmaceuticals S.p.A.

Address
Via Antonio Meucci 3

Sponsor Overview

assignment
1
sponsored trial
science
0
molecules
location_city
37
research centres
public
9
countries
person_search
35
investigators

Specializations

Psychiatry and Schizophrenia

Newron Pharmaceuticals S.p.A. is active in psychiatric research with a clear focus on treatment-resistant schizophrenia, an area of high unmet clinical need within severe mental health disorders.

  • Schizophrenia symptom control
  • Treatment-resistant psychiatric disease
  • Antipsychotic non-response

The sponsor’s clinical work in this field centers on patients whose symptoms remain difficult to manage despite ongoing antipsychotic treatment.

Neuropsychiatric Therapeutics

The company’s research landscape includes neuropsychiatric drug development aimed at improving outcomes in chronic disorders affecting cognition, perception, and behavior.

  • Symptom improvement in schizophrenia
  • Central nervous system therapeutics
  • Persistent psychotic symptoms

Its funded studies reflect interest in therapeutic options for patients with ongoing illness burden despite standard care.

Safety and Tolerability in Long-Term Psychiatric Care

Clinical research supported by the sponsor also addresses the safety and tolerability of treatments used in people receiving stable background psychiatric medication.

  • Treatment-emergent adverse events
  • Serious adverse events
  • Discontinuation due to adverse effects

This area is relevant to patients requiring sustained management of severe psychiatric symptoms while maintaining existing therapy.

Sponsored Trials

Trial Name Country Status
Efficacy and Safety of Evenamide as an Adjunctive Treatment in Patients with Treatment-Resistant Schizophrenia on Stable Antipsychotic TherapyBulgaria BulgariaCroatia CroatiaCzechia CzechiaFrance FranceGermany GermanyHungary HungaryItaly ItalyPoland PolandSpain SpainRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)

This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 37 sites collaborated multiple times

This sponsor has worked with 37 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Mental Disorders1 trial
    150 other sponsors

Partnered Research Centres

37 centres
location_city
assignment1
"Medical Center Mentalcare" Ltd.
Address
107 "Aleksandar Stamboliyski" Blvd., 4000 Plovdiv
Learn morearrow_forward
location_city
assignment1
"Mental Health Center – Veliko Tarnovo" EOOD, Veliko Tarnovo
Address
1 "Buzludzha" Blvd., 5000 Veliko Tirnovo
Learn morearrow_forward
location_city
assignment2
"Multiprofile Hospital for Active Treatment Dr. Hristo Stambolski" EOOD, Kazanlak
Address
16 "Starozagorska" Str., 6100 Kazanlak
Learn morearrow_forward
location_city
assignment39
A-Shine s.r.o.
Address
Sumavska 2, Vychodni Predmesti, 301 00 Pilsen
Learn morearrow_forward
location_city
assignment560
Azienda Ospedaliera Universitaria Federico II Di Napoli
Address
Via Sergio Pansini 5, 80131 Naples
Learn morearrow_forward
location_city
assignment283
Azienda Ospedaliera Universitaria Universita' Degli Studi Della Campania Luigi Vanvitelli
Address
Piazza Luigi Miraglia 2, 80138 Naples
Learn morearrow_forward
Page 1 of 7

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Newron Pharmaceuticals S.p.A..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.